Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Market Cap	41.30M
Revenue (ttm)	79.99M
Net Income (ttm)	4.07M
Shares Out	35.00M
EPS (ttm)	0.12
PE Ratio	10.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	814,198
Average Volume	74,391
Open	1.180
Previous Close	1.180
Day's Range	1.170 - 1.180
52-Week Range	1.090 - 1.310
Beta	0.27
RSI	65.52
Earnings Date	Feb 11, 2026

About ASE:DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. It operates through Medicine; and Infants’ Cereals and Milk Formula segments. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatolog...

• Industry: Pharmaceutical Preparations
• Founded: 1975
• Employees: 1,111
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: DADI

Financial Performance

In 2024, ASE:DADI's revenue was 81.18 million, an increase of 8.42% compared to the previous year's 74.88 million. Earnings were 3.59 million, an increase of 13.41%.